Global Primary Biliary Cirrhosis Drug Market Data Survey Report 2025
- HEY2811118
- 67 Pages
- November 2018
- Medical Devices
The global Primary Biliary Cirrhosis Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc.
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Major applications as follows:
Clinic
Hospital
Others
Major Type as follows:
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 AlbireoPharma
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 CymaBay Therapeutics, Inc.
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Dr. Falk Pharma GmbH
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Enanta Pharmaceuticals, Inc.
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 GlaxoSmithKline Plc
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Intercept Pharmaceuticals, Inc.
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Intercept Pharmaceuticals, Inc.
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 MediGene AG
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 NGM Biopharmaceuticals, Inc.
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Virobay Inc.
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Clinic
4.1.1 Overview
4.1.2 Clinic Market Size and Forecast
4.2 Hospital
4.2.1 Overview
4.2.2 Hospital Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.1 Budesonide
5.1.1 Overview
5.1.2 Budesonide Market Size and Forecast
5.2 FFP-104
5.2.1 Overview
5.2.2 FFP-104 Market Size and Forecast
5.3 GSK-2330672
5.3.1 Overview
5.3.2 GSK-2330672 Market Size and Forecast
5.4 MBX-8025
5.4.1 Overview
5.4.2 MBX-8025 Market Size and Forecast
5.5 NGM-282
5.5.1 Overview
5.5.2 NGM-282 Market Size and Forecast
5.6 NGM-282
5.6.1 Overview
5.6.2 NGM-282 Market Size and Forecast
6 Conclusion
Tab Regional Production 2012-2017 (Volume)
Tab Regional Demand and CAGR 2012-2017 (Million USD)
Tab Regional Demand and CAGR 2012-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AlbireoPharma
Tab Sales Revenue, Volume, Price, Cost and Margin of CymaBay Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Dr. Falk Pharma GmbH
Tab Sales Revenue, Volume, Price, Cost and Margin of Enanta Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of Intercept Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Intercept Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of MediGene AG
Tab Sales Revenue, Volume, Price, Cost and Margin of NGM Biopharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Virobay Inc.
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
